Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:22 pm Purchase |
2025-04-14 | 13G | Athira Pharma, Inc. ATHA |
Steven Michael Oliveira | 1,994,649 5.109% |
1,994,649 (New Position) |
Filing History |
| 2025-01-10 8:13 pm Purchase |
2024-11-20 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 432,276 6.760% |
432,276 (New Position) |
Filing History |
| 2024-04-29 11:44 am Purchase |
2024-04-22 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 791,235 8.890% |
693,032 (+705.71%) |
Filing History |
| 2023-08-18 10:50 am Sale |
2023-08-08 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 98,203 3.890% |
-24,395 (-19.90%) |
Filing History |
| 2022-10-07 12:46 pm Purchase |
2022-09-14 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 122,598 8.080% |
83,297 (+211.94%) |
Filing History |
| 2022-05-09 4:29 pm Sale |
2022-05-02 | 13G | Peak Bio, Inc. PKBOW |
Steven Michael Oliveira | 0 0.000% |
-400,000 (Position Closed) |
Filing History |
| 2022-03-09 11:18 am Purchase |
2022-03-07 | 13G | Trevi Therapeutics, Inc. TRVI |
Steven Michael Oliveira | 1,340,000 5.180% |
1,340,000 (New Position) |
Filing History |
| 2022-03-02 5:24 pm Sale |
2022-02-23 | 13G | 4D pharma plc LBPS |
Steven Michael Oliveira | 8,913,432 4.940% |
-1,305,000 (-12.77%) |
Filing History |
| 2022-02-03 10:39 am Sale |
2022-02-02 | 13G | 4D pharma plc LBPS |
Steven Michael Oliveira | 10,218,432 5.670% |
-10,664,994 (-51.07%) |
Filing History |
| 2022-01-19 3:20 pm Purchase |
2022-01-18 | 13G | Renovacor, Inc. RCOR |
Steven Michael Oliveira | 575,000 3.330% |
575,000 (New Position) |
Filing History |
| 2021-09-21 1:31 pm Sale |
2021-09-07 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 0 0.000% |
-26,043 (Position Closed) |
Filing History |
| 2021-04-14 5:17 pm Purchase |
2021-04-12 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 39,301 13.870% |
16,061 (+69.11%) |
Filing History |
| 2021-04-12 06:09 am Purchase |
2021-03-22 | 13G | 4D pharma plc LBPS |
Steven Michael Oliveira | 20,883,426 11.670% |
20,883,426 (New Position) |
Filing History |
| 2021-04-05 06:01 am Purchase |
2021-04-01 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 23,240 8.200% |
23,240 (New Position) |
Filing History |
| 2021-02-16 3:20 pm Purchase |
2020-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 26,043 5.100% |
3,600 (+16.04%) |
Filing History |
| 2021-02-16 3:16 pm Purchase |
2021-02-16 | 13G | LONGEVITY ACQUISITION CORP USD LOAC |
Steven Michael Oliveira | 212,479 8.100% |
37,293 (+21.29%) |
Filing History |
| 2021-02-16 2:51 pm Sale |
2020-12-31 | 13G | Monterey Capital Acquisition Corporation MCAC |
Steven Michael Oliveira | 0 0.000% |
-650,000 (Position Closed) |
Filing History |
| 2021-02-02 06:10 am Purchase |
2021-01-28 | 13G | Peak Bio, Inc. PKBOW |
Steven Michael Oliveira | 400,000 6.300% |
400,000 (New Position) |
Filing History |
| 2020-10-27 10:51 am Purchase |
2020-10-23 | 13G | LONGEVITY ACQUISITION CORP USD LOAC |
Steven Michael Oliveira | 175,186 6.670% |
175,186 (New Position) |
Filing History |
| 2020-09-01 09:10 am Purchase |
2020-08-28 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 22,443 5.010% |
22,443 (New Position) |
Filing History |